Association Between Visceral Fat, Blood Pressure and Arterial Stiffness in Patients with HFpEF: A Mediation Analysis
Min Sun,Lei Gao,Hongmei Bai,Weiwei Hu,Xiaofang Zhang,Jin Xiao,Xiangliang Deng,Hongmei Tao,Ping Ge,Yuhong Qin,Dongying Zhang
DOI: https://doi.org/10.2147/DMSO.S399928
2023-03-09
Abstract:Min Sun, 1, 2 Lei Gao, 1 Hongmei Bai, 1 Weiwei Hu, 1 Xiaofang Zhang, 1 Jin Xiao, 1 Xiangliang Deng, 1 Hongmei Tao, 1 Ping Ge, 2 Yuhong Qin, 1, &ast Dongying Zhang 1, &ast 1 Department of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China; 2 Health Management Center, The First Branch of the Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Dongying Zhang; Yuhong Qin, Tel +86-23-13608398395 ; +86-23-13068357151, Email ; Purpose: To investigate the association of visceral fat with arterial stiffness of heart failure patients with preserved ejection fraction (HFpEF) and to evaluate the extent to which this association is mediated by blood pressure (BP). Patients and Methods: This cross-sectional descriptive study (clinicaltrials.gov identifier: NCT04535726) recruited 94 patients with HFpEF totally from October to December 2020. The obesity-related measurements included visceral fat area (VFA), body mass index (BMI), waist circumference (WC), hip circumference (HC), waist–hip ratio (WC/HC), abdominal circumference (AC), body fat mass and fat percentage. Brachial-ankle pulse wave velocity (baPWV) was used to estimate the degree of arterial stiffness. Mediation analysis was performed to reveal whether the effect of visceral fat area on arterial stiffness can be mediated by BP in patients with HFpEF and the extent to which this association was mediated by BP. Results: About 93.6% of HFpEF patients were accompanied with abdominal obesity. Patients in baPWV ≥ 1800cm/s group were older, with a higher incidence of type 2 diabetes mellitus (T2DM), hypertension and abdominal obesity. VFA, systolic BP (SBP), diastolic BP (DBP) and pulse pressure (PP) were correlated with baPWV in total group. Adjusted for age ≥ 75 years old, gender, smoking, T2DM, calcium channel blocker and statins, the mediation effect of systolic SBP and PP on the VFA-baPWV association were 53.3% (indirect effect was 2.28, 95% CI 0.62– 4.73) and 48.4% (indirect effect was 2.07, 95% CI 0.51– 4.38), respectively. DBP failed to mediate the association between VFA and baPWV (indirect effect was 0.50, 95% CI − 0.41– 2.14). Conclusion: The association of visceral fat with baPWV in HFpEF patients may be partly accounted for SBP or PP. Elevated SBP and PP might be important potential targets for preventing arterial stiffness in HFpEF patients. Keywords: mediation analysis, blood pressure, visceral fat area, brachial-ankle pulse wave velocity, HFpEF Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disease with typical diastolic dysfunction of the left ventricle (LV). 1,2 Studies had proven that arterial stiffness, which means the decrement of arterial compliance, was an important harmful factor for LV diastolic function and HFpEF. 3,4 Brachial-ankle pulse wave velocity (baPWV) is a widely used measure for arterial stiffness, and numerous studies had found baPWV to be associated with visceral fat, waist circumference (WC), and body mass index (BMI), 5–7 while the underlying mechanism of these observations is not fully understood. Blood pressure (BP) as a leading promoter of arterial stiffness might mediate the association of BMI with baPWV. 8–10 Compared with systemic obesity evaluated by BMI, abdominal obesity was the main form of Chinese HFpEF patients 11–13 and may cause more serious adverse consequences in obese HFpEF patients. 14 Thus, a key unsolved mystery for HFpEF-patient health is the extent to which the effect of abdominal obesity on baPWV might be mediated by BP. To address this concern, we applied a mediation analysis to investigate the extent of blood pressure mediated the association of visceral fat area (VFA, a method to measure abdominal obesity) 15 with baPWV within HFpEF. A total of 131 patients with HFpEF were recruited to the study from October to December 2020. The eligible subjects at screening required an age over 50 years, signs and symptoms of heart failure, an ejection fraction of 50% or higher, elevated level of natriuretic peptides or B-type natriuretic peptide (with different cutoffs depending on whether the rhythm was sinus or atrial fibrillation and/or flutter: sinus rhythm at least higher than 125 pg/mL, fibrillation and/or flutter rhythm at least higher than 365 pg/mL), changes in the structure and/or function of the heart and the HFA-PEFF score ≥5 points (details see the consensus recommenda -Abstract Truncated-
endocrinology & metabolism